Nisa Investment Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.3K Buy
2,822
+34
+1% +$305 ﹤0.01% 1828
2025
Q1
$20.9K Buy
2,788
+294
+12% +$2.21K ﹤0.01% 1854
2024
Q4
$18.8K Sell
2,494
-75
-3% -$564 ﹤0.01% 1955
2024
Q3
$19.5K Buy
2,569
+476
+23% +$3.62K ﹤0.01% 1916
2024
Q2
$12.9K Buy
2,093
+3
+0.1% +$19 ﹤0.01% 2071
2024
Q1
$10.6K Buy
2,090
+180
+9% +$914 ﹤0.01% 2026
2023
Q4
$11.4K Sell
1,910
-3,415
-64% -$20.5K ﹤0.01% 2014
2023
Q3
$37.7K Buy
5,325
+34
+0.6% +$241 ﹤0.01% 1812
2023
Q2
$37.2K Buy
5,291
+3,371
+176% +$23.7K ﹤0.01% 1852
2023
Q1
$16K Sell
1,920
-4,430
-70% -$36.9K ﹤0.01% 2064
2022
Q4
$73K Buy
6,350
+11
+0.2% +$126 ﹤0.01% 1658
2022
Q3
$85K Buy
6,339
+129
+2% +$1.73K ﹤0.01% 1559
2022
Q2
$66K Hold
6,210
﹤0.01% 1638
2022
Q1
$101K Sell
6,210
-730
-11% -$11.9K ﹤0.01% 1612
2021
Q4
$107K Sell
6,940
-4,560
-40% -$70.3K ﹤0.01% 1493
2021
Q3
$165 Hold
11,500
﹤0.01% 1481
2021
Q2
$182 Sell
11,500
-425
-4% -$7 ﹤0.01% 1441
2021
Q1
$121 Buy
11,925
+9,000
+308% +$91 ﹤0.01% 1667
2020
Q4
$22K Buy
2,925
+850
+41% +$6.39K ﹤0.01% 2103
2020
Q3
$7K Hold
2,075
﹤0.01% 2160
2020
Q2
$10K Buy
2,075
+105
+5% +$506 ﹤0.01% 1916
2020
Q1
$4K Buy
+1,970
New +$4K ﹤0.01% 1968
2017
Q2
Sell
-1,000
Closed -$8K 1837
2017
Q1
$8K Buy
+1,000
New +$8K ﹤0.01% 1724
2016
Q2
Sell
-2,600
Closed -$7K 1861
2016
Q1
$7K Buy
+2,600
New +$7K ﹤0.01% 1814